‌

US Patent 9144563 Treatment of triple receptor negative breast cancer

Patent 9144563 was granted and assigned to MediGene on September, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

MediGene

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9144563

Date of Patent

September 29, 2015

Patent Application Number

13430393

Date Filed

March 26, 2012

Patent Primary Examiner

‌

Gollamudi Kishore

Patent abstract

The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9144563 Treatment of triple receptor negative breast cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API